Farms.com Home   News

Corn leafhopper keeps pathologists on alert

In the battle against crop diseases, the game is always changing, providing fresh challenges for farmers and plant pathologists.

Plant diseases such as red crown rot in soybeans are moving into more parts of the Midwest, and last year, Extension personnel in Missouri and Oklahoma identified corn leafhopper and corn stunt disease in their states for the first time, pushed up from the South.

The corn leafhopper is a tiny insect that carries pathogens that causes corn stunt disease, which can reduce growth, development and yield. The insects can also cause damage by feeding on corn.

Ashleigh Faris, Oklahoma State University cropping systems Extension entomologist, says corn leafhoppers have populations in Texas and made their way north, likely aided by storms or strong winds. She remembers receiving the call to check a south-central Oklahoma field around the end of July.

“Last year we received our first call about there possibly being something in a corn field they didn’t know what it was,” Faris says. “…We saw evidence of heavy corn stunting.”

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.